人AnnexinV/Annexin A5重组蛋白(>98%)

特别提示：包括人AnnexinV/Annexin A5重组蛋白在内，本公司的所有产品仅可用于科研实验，严禁用于临床YL及其他非科研用途！

产品名称：人AnnexinV/Annexin A5重组蛋白
英文名称：Recombinant Human AnnexinV/Annexin A5
产品货号：ZN1558
产品规格：100ng

来源：大肠杆菌
特异性：人
应用：WB 阳性对照
形态：冻干粉
纯度：>98%，RP-HPLC&SDS-PAGE
保存条件：-20℃保存 1 年以上，避免反复冻融。

根据您的关注的人AnnexinV/Annexin A5重组蛋白(>98%)，AnnexinV/Annexin A5，Recombinant Human AnnexinV/Annexin A5，重组AnnexinV/Annexin A5，您可能还对以下产品有需求：


JN0590 重组人非转移性黑色素瘤糖蛋白B(GPNMB) 10μg|50μg|500μg|1mg
JN0611 重组人丛状蛋白结构域1(PLXDC1) 10μg|50μg|500μg|1mg
JN0675 重组人尿卟啉原脱羧酶(UROD) 10μg|50μg|500μg|1mg
JN0687 重组人BCAS2(乳腺癌扩增序列2) 10μg|50μg|500μg|1mg
JN0767 重组人CEACAM7(癌胚抗原相关细胞粘附分子7) 10μg|50μg|500μg|1mg
JN0852 重组人含吩嗪合成类结构域蛋白(PBLD) 10μg|50μg|500μg|1mg
JN1008 重组人CAPN2(钙蛋白酶2催化亚单位) 10μg|50μg|500μg|1mg

关注人AnnexinV/Annexin A5重组蛋白(>98%)，AnnexinV/Annexin A5，Recombinant Human AnnexinV/Annexin A5，重组AnnexinV/Annexin A5的同时，为您推荐更多您可能感兴趣的产品：



名称：重组人白介素IL-31(白细胞介素31)
货号：JN0346
规格：10μg|50μg|500μg|1mg
本品由我们的大肠杆菌表达系统制备，目的基因编码的Ser24-Thr164表达纯化而来。

IL-31质量控制：＞95%(还原性SDS-PAGE)。

IL-31制剂：冻干品

IL-31保存：
冻干蛋白可在-20℃长期保存，室温也可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天。
复溶后建议分装冻存在-20℃，可保存3个月，应避免反复冻融。

IL-31复溶：
1、试剂开盖前请先离心。
2、复溶浓度应大于100 μg/ml.
3、冻干蛋白溶于ddH2O中
4、复溶后根据使用量分装保存，避免反复冻融。

关于IL-31：
Human Interleukin 31 (IL-31) is a cytokine containing a four-helix bundle structure. It shares several structural and functional characteristics with IL-6, Oncostatin M, LIF, and Cardiotrophin-1. Human IL-31 cDNA encodes a 164 amino acid precursor that contains a 23 amino acid signal peptide and a 141 amino acid mature protein. Human and mouse IL-31 share 24% sequence identity in the mature region. IL-31 is mainly associated with activated T cells and is preferentially expressed by type 2 helper T cells (Th2). IL-31 signals via a heterodimeric receptor complex composed of a gp130 related molecule termed IL-31RA (also GPL and GLMR) and an Oncostatin M receptor (OSM Rβ). The IL-31 receptor is constitutively expressed by keratinocytes and upregulated by IFNγ on monocytes. GPL/OSMR signaling is a strong activator of STAT3 and STAT5, and can also activate STAT1, Jak1, and Jak2 signaling pathways. IL-31 regulated immune responses have been implicated in skin physiology and inflammatory skin diseases. Studies have shown that IL31 induces severe pruritis (itching) and dermatitis in transgenic mice.